ReCGiP: Database of Reproduction Candidate Genes in Pigs based on bibliomics

Placentation

Pathway Foreground Gene Count & Ratio Background Gene Count & Ratio p-value q-value
Bladder cancer 6 / 18.18% 40 / 0.50% 2.42E-08 None
Renal cell carcinoma 6 / 18.18% 67 / 0.83% 4.07E-07 None
Focal adhesion 8 / 24.24% 199 / 2.48% 1.32E-06 None
Cytokines 8 / 24.24% 229 / 2.85% 3.63E-06 None
Cytokine-cytokine receptor interaction 8 / 24.24% 275 / 3.42% 1.35E-05 None
Natural killer cell mediated cytotoxicity 6 / 18.18% 142 / 1.77% 2.54E-05 None
Type I diabetes mellitus 4 / 12.12% 44 / 0.55% 3.98E-05 None
mTOR signaling pathway 4 / 12.12% 48 / 0.60% 5.48E-05 None
Renin - angiotensin system 3 / 9.09% 17 / 0.21% 6.79E-05 None
Axon guidance 5 / 15.15% 127 / 1.58% 1.79E-04 None
Pancreatic cancer 4 / 12.12% 69 / 0.86% 2.07E-04 None
Melanoma 4 / 12.12% 71 / 0.88% 2.30E-04 None
CAM ligands 5 / 15.15% 152 / 1.89% 4.01E-04 None
GnRH signaling pathway 4 / 12.12% 94 / 1.17% 6.40E-04 None
Regulation of actin cytoskeleton 5 / 15.15% 213 / 2.65% 1.76E-03 None
Adherens junction 3 / 9.09% 72 / 0.90% 3.45E-03 None
Hematopoietic cell lineage 3 / 9.09% 81 / 1.01% 4.75E-03 None
Dorso-ventral axis formation 2 / 6.06% 24 / 0.30% 4.96E-03 None
Colorectal cancer 3 / 9.09% 86 / 1.07% 5.58E-03 None
TGF-beta signaling pathway 3 / 9.09% 87 / 1.08% 5.76E-03 None
Antigen processing and presentation 3 / 9.09% 88 / 1.10% 5.94E-03 None
Thyroid Cancer 2 / 6.06% 29 / 0.36% 7.01E-03 None
Leukocyte transendothelial migration 3 / 9.09% 113 / 1.41% 1.16E-02 None
Cellular antigens 6 / 18.18% 480 / 5.98% 1.28E-02 None
Type II diabetes mellitus 2 / 6.06% 41 / 0.51% 1.32E-02 None
Cell adhesion molecules (CAMs) 4 / 12.12% 242 / 3.01% 1.73E-02 None
Endometrial cancer 2 / 6.06% 51 / 0.63% 1.96E-02 None
Non-small cell lung cancer 2 / 6.06% 53 / 0.66% 2.11E-02 None
Glioma 2 / 6.06% 64 / 0.80% 2.96E-02 None
Epithelial cell signaling in Helicobacter pylori infection 2 / 6.06% 65 / 0.81% 3.04E-02 None
Calcium signaling pathway 3 / 9.09% 171 / 2.13% 3.35E-02 None
Fc epsilon RI signaling pathway 2 / 6.06% 70 / 0.87% 3.47E-02 None
ECM-receptor interaction 2 / 6.06% 84 / 1.05% 4.79E-02 None
ErbB signaling pathway 2 / 6.06% 84 / 1.05% 4.79E-02 None

Query Genes

Bladder cancer 4313;  5594;  4318;  5228;  1956;  7422;  
Renal cell carcinoma 5228;  5594;  3091;  7422;  4233;  3082;  
Focal adhesion 3688;  5594;  5228;  3678;  1956;  7422;  4233;  3082;  
Cytokines 1948;  5228;  3589;  3458;  7422;  7124;  284;  3082;  
Cytokine-cytokine receptor interaction 5228;  3589;  3458;  1956;  7422;  7124;  4233;  3082;  
Natural killer cell mediated cytotoxicity 3806;  5594;  3458;  3107;  3135;  7124;  
Type I diabetes mellitus 3135;  7124;  3107;  3458;  
mTOR signaling pathway 3091;  5228;  5594;  7422;  
Renin - angiotensin system 183;  1636;  185;  
Axon guidance 2050;  1948;  3688;  4233;  5594;  
Pancreatic cancer 1956;  5228;  5594;  7422;  
Melanoma 1956;  4233;  5594;  3082;  
CAM ligands 3491;  4313;  5228;  7422;  3082;  
GnRH signaling pathway 1956;  4313;  5594;  1081;  
Regulation of actin cytoskeleton 3688;  3678;  1956;  5594;  2149;  
Adherens junction 1956;  4233;  5594;  
Hematopoietic cell lineage 3589;  7124;  3678;  
Dorso-ventral axis formation 1956;  5594;  
Colorectal cancer 1956;  4233;  5594;  
TGF-beta signaling pathway 7124;  3458;  5594;  
Antigen processing and presentation 3135;  3806;  3107;  
Thyroid Cancer 5468;  5594;  
Leukocyte transendothelial migration 4318;  3688;  4313;  
Cellular antigens 3688;  1636;  3107;  3135;  3678;  4233;  
Type II diabetes mellitus 7124;  5594;  
Cell adhesion molecules (CAMs) 3135;  3678;  3688;  3107;  
Endometrial cancer 1956;  5594;  
Non-small cell lung cancer 1956;  5594;  
Glioma 1956;  5594;  
Epithelial cell signaling in Helicobacter pylori infection 1956;  4233;  
Calcium signaling pathway 1956;  2149;  185;  
Fc epsilon RI signaling pathway 7124;  5594;  
ECM-receptor interaction 3678;  3688;  
ErbB signaling pathway 1956;  5594;